Iconovo receives positive guidance from FDA regarding substitutability for ICOpre

Iconovo announces that the US Food and Drug Administration (FDA) has issued a positive guidance regarding the generic substitutability of the company's…

BIOSTOCK: The future of obesity treatment – Iconovo develops intranasal semaglutide

This morning, BIOSTOCK released an article regarding Iconovo's development of an intranasal semaglutide formulation for the treatment of obesity in the…

Iconovo develops intranasally inhaled semaglutide in ICOone Nasal for more user-friendly treatment of overweight and obesity

Iconovo announced today that the company has initiated the development of the GLP-1 analogue semaglutide in the inhaler ICOone Nasal for intranasal treatment…

Systemic Delivery of Biologics via Inhalation: Overcoming Injection Aversion in Modern Therapies

That was the title of the talk by Dr Orest Lastow, CTO at Iconovo, at the meeting New updates in Drug Formulation & Bioavailability organized by Life Science…

Grundaren av Iconovo, Dr Orest Lastow, om att vara sci-fi-författare

Grundaren av Iconovo, Dr Orest Lastow, har blivit intervjuad av Life Science Sweden om sin nya parallella karriär som sci-fi-författare. Orest kombinerar…

EU Business News has awarded Iconovo as the Best Inhalation Therapy Company 2024!

Iconovo is one of the 2024 winners of Scandinavian Business Awards at EU Business News. Iconovo was awarded as Best Inhalation Therapy Company 2024. …

About Q2-2024 report by CEO Johan Wäborg at Carnegie

Iconovo released the Q2-2024 report today and the CEO at Iconovo, Johan Wäborg was invited to the Carnegie Bank studio to comment and give some more flavor…

Iconovo releases Q2-2024 report

“A quarter of intense business development and constructive negotiations." says Johan Wäborg, CEO at Iconovo. CEO MESSAGES:  STRATEGIC INITIATIVES…

Dr Orest Lastow presenting Systemic Delivery of Biologics via Inhalation: Overcoming Injection Aversion in Modern Therapies

Iconovo to present at New Updates in Drug Formulation & Bioavailability in Copenhagen August 28th. Dr Orest Lastow, CTO at Iconovo will present on…

Iconovo attends Carnegie Healthcare Webinar

Iconovo CEO Johan Wäborg gives a company presentation at Carnegie Healthcare Webinar. In the video you can hear him go through the company, the strategies…